Published in Antimicrob Agents Chemother on May 01, 1997
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother (1999) 7.94
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother (2000) 4.31
Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother (2001) 4.17
Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol (2013) 3.32
Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother (2000) 3.00
Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother (2002) 2.07
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother (1998) 1.76
Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63
Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol (2003) 1.48
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One (2012) 1.34
Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother (2004) 1.32
Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob Agents Chemother (2009) 1.30
Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother (2002) 1.17
Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species. J Clin Microbiol (2000) 1.11
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol (2000) 1.09
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic. Antimicrob Agents Chemother (2007) 0.92
Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob Agents Chemother (2004) 0.92
Draft genome sequence of an antibiotic-resistant Propionibacterium acnes strain, PRP-38, from the novel type IC cluster. J Bacteriol (2012) 0.89
Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge. Appl Environ Microbiol (2007) 0.82
A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes. Antimicrob Agents Chemother (2015) 0.76
In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA. J Antibiot (Tokyo) (2017) 0.75
Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes. Antimicrob Agents Chemother (2007) 0.75
Ribosomal mutations conferring macrolide resistance in Legionella pneumophila. Antimicrob Agents Chemother (2017) 0.75
Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients. Front Microbiol (2017) 0.75
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother (1995) 9.40
PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol (1994) 6.33
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother (1995) 3.22
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother (1987) 2.80
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother (1995) 2.58
Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31
Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J (1988) 1.89
Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol (1983) 1.67
Mechanisms for gene conversion and homologous recombination: the double-strand break repair model and the successive half crossing-over model. Adv Biophys (1992) 1.64
Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem (1992) 1.54
Erythromycin binding is reduced in ribosomes with conformational alterations in the 23 S rRNA peptidyl transferase loop. J Mol Biol (1993) 1.53
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol (1989) 1.40
Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol (1979) 1.07
Gene conversion as a focusing mechanism for correlated mutations: a hypothesis. Mol Gen Genet (1996) 1.01
Mutations in domain II of 23 S rRNA facilitate translation of a 23 S rRNA-encoded pentapeptide conferring erythromycin resistance. J Mol Biol (1996) 0.91
Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes. J Antimicrob Chemother (1989) 0.89
The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation. J Dermatol (1988) 0.88
Ligation- and PCR-based method for sequencing plasmid inserts. Biotechniques (1995) 0.82
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol (1990) 4.03
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The rate of sebum excretion in man. Br J Dermatol (1969) 2.68
Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother (1989) 2.62
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol (2002) 2.34
Evaluation of the modified Alvarado score in the diagnosis of acute appendicitis: a prospective study. Ann R Coll Surg Engl (1994) 2.32
Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Lancet (1969) 2.28
Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers. Br J Surg (1997) 2.26
Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother (1993) 2.25
Antibiotic-resistant acne: lessons from Europe. Br J Dermatol (2003) 2.22
Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg (1993) 2.16
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
Pathogenesis of acne. Lancet (1969) 2.10
Suicide in dermatological patients. Br J Dermatol (1997) 2.07
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
Intracellular copper routing: the role of copper chaperones. Trends Biochem Sci (2000) 2.02
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Post-adolescent acne: a review of clinical features. Br J Dermatol (1997) 1.94
A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol (1994) 1.88
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
The prevalence of acne vulgaris in adolescence. Br J Dermatol (1971) 1.72
Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg (1984) 1.68
Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination. Dis Colon Rectum (2001) 1.67
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol (1989) 1.65
Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J (1979) 1.64
Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol (1990) 1.61
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res (1990) 1.61
Disseminated intravascular coagulation and fetal hydrops in a newborn infant in association with a chorangioma of placenta. Pediatrics (1972) 1.58
Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene (1995) 1.57
The cause of post-traumatic pulmonary insufficiency in man. Surg Gynecol Obstet (1975) 1.53
Genetic control of sebum excretion and acne--a twin study. Br J Dermatol (1988) 1.47
The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol (1997) 1.47
Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Ther Drug Monit (1998) 1.45
Interactions between the oral contraceptive pill and antibiotics. Br J Dermatol (1990) 1.45
Is a preemployment chest radiograph necessary for NHS employees? Br Med J (Clin Res Ed) (1988) 1.45
Prevalence of facial acne in adults. J Am Acad Dermatol (1999) 1.42
Alopecia areata treated with diphencyprone: is an allergic response necessary? Br J Dermatol (1990) 1.42
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer (1998) 1.40
The inter-relationship between isotretinoin/acne and depression. J Eur Acad Dermatol Venereol (1999) 1.40
Fabrication and reorganization of dermal equivalents suitable for skin grafting after major cutaneous injury. Biomaterials (1990) 1.40
Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol (1996) 1.40
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol (1989) 1.40
Acne vulgaris and malignancy. Br J Dermatol (1988) 1.38
Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care (2011) 1.38
Perinatal mortality and one-year infant morbidity. Br Med J (1978) 1.37
Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol (1996) 1.35
13-cis retinoic acid and acne. Lancet (1980) 1.33
Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment. Br J Dermatol (1993) 1.27
Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun (1998) 1.27
Modification of human prekeratin during epidermal differentiation. Biochem J (1981) 1.27
The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol (1998) 1.25
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Nitrogen management is essential to prevent tropical oil palm plantations from causing ground-level ozone pollution. Proc Natl Acad Sci U S A (2009) 1.24
A dose-response study of I3-cis-retinoic acid in acne vulgaris. Br J Dermatol (1983) 1.23
Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol (1991) 1.22
On the androgen microenvironment of maturing spermatozoa. Endocrinology (1984) 1.22
Role of the occupational health service in screening and increasing the uptake of rubella immunisation. Br Med J (Clin Res Ed) (1985) 1.21
Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care (2009) 1.21
Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol (1993) 1.20
Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol (1969) 1.19
The assessment of acne vulgaris--the Leeds technique. Br J Dermatol (1984) 1.18
Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. Br J Dermatol (1969) 1.17
Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev (2003) 1.16
Hereditary gingival fibromatosis. Br Med J (1969) 1.16
Properties of gastric and duodenal mucus: effect of proteolysis, disulfide reduction, bile, acid, ethanol, and hypertonicity on mucus gel structure. Gastroenterology (1985) 1.15
Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol (2001) 1.15
The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol (2000) 1.14
Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology (1984) 1.13
Sebum excretion in acromegaly. Br Med J (1972) 1.13
Copper chaperones: function, structure and copper-binding properties. J Biol Inorg Chem (1999) 1.12
Acne and unemployment. Br J Dermatol (1986) 1.12
Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene (1996) 1.12
Pancreatic abscess. Am J Surg (1975) 1.10
Delineation of critical factors in the treatment of pancreatic trauma. Surgery (1976) 1.09
Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood (1994) 1.08
Generalized hyperhidrosis following epilepsy. Br J Dermatol (1971) 1.08
The effect of trimethoprim-sulphamethoxazole on sebum excretion rate and biochemistry in acne vulgaris. Br J Dermatol (1971) 1.07
The atmospheric chemistry of trace gases and particulate matter emitted by different land uses in Borneo. Philos Trans R Soc Lond B Biol Sci (2011) 1.07
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1990) 1.07
Effect of allopurinol on hemorrhagic shock. Am J Physiol (1969) 1.07